Patients with Hepatic impairment - Hepatic impairment doesn't have any impact on the publicity of semaglutide. The pharmacokinetics of semaglutide have been evaluated in people with distinctive degrees of hepatic impairment (gentle, moderate, critical) as opposed with subjects with usual hepatic